{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01599728: Not Applicable Interventional Completed Heart Failure
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01599728: Not Applicable Interventional Completed Heart Failure
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01399684: Phase 2 Interventional Completed Metastatic Colorectal Cancer
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02289898: Phase 2 Interventional Completed Pancreatic Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00037687: Phase 3 Interventional Terminated Sepsis
(2001)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Class:
PROTEIN
Class:
PROTEIN
Dumorelin is a 27-L-Leu-44a-Gly peptide. It is a stimulator of human growth hormone release.
Status:
Investigational
Source:
NCT00496652: Phase 3 Interventional Completed Cancer of the Head and Neck
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00379132: Phase 1 Interventional Completed Breast Cancer
(2006)
Source URL:
Class:
PROTEIN
Chlorotoxin is a disulfide-rich stable peptide from the venom of the Israeli scorpion Leiurus quinquestriatus, which has potential therapeutic applications in the treatment of cancer. Chlorotoxin is the first reported high-affinity peptide blocker for small conductance chloride channels. Chlorotoxin is able to penetrate blood-brain-barrier and binds preferentially to tumor cells, making the design of therapeutics using chlorotoxin as a scaffold to treat glioma and other types of cancer of neuroectodermal origins such as melanoma, neuroblastoma, and medulloblastoma possible. To date, no obvious toxicities nor immunogenic responses after being administered to humans have been reported
